NIH-funded research R01 grant

Newborn sequencing with rapid, affordable protein tagging to map amino-acid changes

Official title: Massively Parallel Biochemical Annotation of Missense DNA Variants to Support Newborn Screening by Whole Genome Sequencing

Funded at University of Washington · NIH-11370044 · Data updated 2026-11-12

A new method will quickly map all possible amino-acid changes in proteins to help interpret newborn genome data for faster, more accurate diagnoses.

More Newborn research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Washington
NIH-funded
Lab location1 site (Seattle, United States)
Project startAugust 23, 2024
Project endJune 30, 2028
Funding year2026
Award (this year)$638,960
NIH project number5R01HD115326-03
Project IDNIH-11370044 on NIH RePORTER

Who could benefit from this research

Could help

Newborns or infants whose health may be affected by genetic variants and whose screening could benefit from more precise interpretation of VOUS.

Less likely to help

Patients without genetic variants of uncertain significance or whose conditions are not linked to amino-acid substitutions may see limited benefit.

What this research studies

This project develops VOUSDO, a technology that links every possible amino-acid change in a protein to a readable barcode, allowing rapid interpretation of genetic variants in newborns. By expressing single protein variants in human cells and capturing barcode signals, it aims to show which substitutions may be harmful. The goal is to reduce false negatives in newborn sequencing by providing biochemical context for variants of unknown significance. If successful, this could streamline early detection of treatable conditions from whole-genome data. The work is conducted using a human-cell system to ensure relevance to patient care.

Why it matters

Potential benefit: If successful, it could improve the speed and accuracy of newborn diagnoses from genome sequencing, enabling earlier treatments.

How similar studies have gone: Prior methods struggled with interpreting VOUS; this approach introduces a scalable, direct biochemical readout which is novel in this context.

Where this research is happening

  • University of Washington
    Seattle, United States
    Active

Researchers

  • Principal investigator: Gelb, Michael H — University of Washington
  • Study coordinator: Gelb, Michael H

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.